Livongo is a recent digital health IPO with a SAAS-style business model that leverages AI to help people manage their chronic conditions.
With revenue growth of 148% and gross margins of 75% in Q3 2019, it is among the fastest-growing public companies.
It has amassed a strong clientele, including 20% of the Fortune 500 such as Target, Pepsi, Microsoft, Merck, and Citigroup.
It is a first-mover with no public competition and an attractive valuation with a two-year forward P/S of 5.3x.
Editor's note: Seeking Alpha is proud to welcome Richard Chu as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free